PROSTATE WARRIORS - The latest news about prostate cancer
  • Home
  • Cancer 1O1
  • News
  • Navigator
  • Newsletters
  • Contact
  • Search
  • Menu Menu
  • X

A New Insight From the ARANOTE Trial for mHSPC

April 30, 2025/0 Comments/in Post-hoc/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-30 09:34:382025-05-06 14:21:27A New Insight From the ARANOTE Trial for mHSPC

Setback in Prostate Cancer Trial: CAPItello-280 Study for Truqap Discontinued

April 30, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 3/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-30 09:22:592025-04-30 09:22:59Setback in Prostate Cancer Trial: CAPItello-280 Study for Truqap Discontinued

Precision in Action: How Logic-Gating Redefines Targeted Therapy

April 29, 2025/0 Comments/in Not PCa related/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-29 16:09:322025-04-29 16:09:32Precision in Action: How Logic-Gating Redefines Targeted Therapy

UPDATE: ATNM-400 a Promising Antibody Radioconjugate Delivering 225 Ac

April 28, 2025/0 Comments/in Preclinical Research/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-28 20:27:142025-04-28 20:27:14UPDATE: ATNM-400 a Promising Antibody Radioconjugate Delivering 225 Ac

OST11098: A Promising New Approach for Castration-Resistant Prostate Cancer

April 28, 2025/0 Comments/in Preclinical Research/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-28 10:53:332025-04-28 10:53:33OST11098: A Promising New Approach for Castration-Resistant Prostate Cancer

Phase 1 Trial: APG-5918 an EED Inhibitor for Prostate Cancer Therapy

April 28, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-28 10:40:362025-04-28 10:40:36Phase 1 Trial: APG-5918 an EED Inhibitor for Prostate Cancer Therapy

SHR3591 Shows Promise in Tackling Resistant Prostate Cancer

April 28, 2025/0 Comments/in Preclinical Research, PROTACs/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-28 10:07:502025-04-28 10:07:50SHR3591 Shows Promise in Tackling Resistant Prostate Cancer

Phase 1 Trial: CTS2190 Targets Advanced Prostate Cancer

April 28, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-28 09:06:202025-04-28 09:06:20Phase 1 Trial: CTS2190 Targets Advanced Prostate Cancer

Phase 1 trial: SYN818 Shows Promise for Prostate Cancer Patients With HRR Genetic Mutations

April 28, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-28 08:44:122025-04-28 08:44:12Phase 1 trial: SYN818 Shows Promise for Prostate Cancer Patients With HRR Genetic Mutations

Phase 1 Trial: NXP900 for Overcoming Resistance in Advanced Prostate Cancer

April 28, 2025/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-28 08:28:102025-04-28 08:28:10Phase 1 Trial: NXP900 for Overcoming Resistance in Advanced Prostate Cancer
Page 1 of 512345

Menu

  • Home
  • Cancer 1O1
  • News
  • Navigator
  • Newsletters
  • Contact

Categories

Archives

  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • September 2023

Project Navigator


Let's try to finance it!

A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.

Tags

225Ac abiraterone acetate ADC AI ai in healthcare alphafold antibody-drug conjugate apalutamide ASCO 2025 ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy CAR-T clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer olaparib oncolytic virus PARP inhibitor personalized medicine Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data theranostics

Latest Posts

  • Nutrition and Inflamation: New Research Unveils Five Universal Patient Clusters in Oncology August 19, 2025
  • Nuanced Benefits of Fasting-Mimicking Diets: High Protein vs. Low Protein August 18, 2025
  • Newsletter 33/2025 August 17, 2025
  • One year (almost) of ProstateWarriors.com and where are we? August 16, 2025
© Copyright 2024 - 2025 PROSTATE WARRIORS - The latest news about prostate cancer - Supporters' Hall
  • X
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlySettings

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Other cookies

The following cookies are also needed - You can choose if you want to allow them:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy Policy
Accept settingsHide notification only